New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Verano Holdings Corp.
VRNOF
Shape
US Flag

PNK

Unprofitable

Unprofitable

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

3.45USD
Shape-0.10 ( -2.80%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-91%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

51%

Quote Panel

Shape
Updated October 29, 2024
1W -12.21 % 1M 3.60 % 3M -13.53 % 1Y 13.11 %

Key Metrics

Shape
  • Market Cap

    1.20B


  • Shares Outstanding

    346.42M


  • Share in Float

    307.94M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    3.45


  • Average Volume

    308454


  • Beta

    1.363


  • Range

    3.01-7.08


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.verano.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.29x

P/S Ratio

0.97x

P/B Ratio

0.3

Debt/Equity

-12.8%

Net Margin

$-0.3

EPS

How VRNOF compares to sector?

P/E Ratio

Relative Strength

Shape

VRNOF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape356%

2025-Revenue

$0.14

Shape-130%

2025-EPS

$154M

Shape130%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.13
vs 0.33

Q4.22

arrow
arrow

+587%

0.04
vs -0.01

Q1.23

arrow
arrow

N/A

-0.03
vs -0.02

Q2.23

arrow
arrow

N/A

-0.04
vs -0.03

Q3.23

arrow
arrow

N/A

-0.03
vs -0.13

Q4.23

arrow
arrow

N/A

-0.07
vs 0.04

Q1.24

arrow
arrow

N/A

-0.01
vs -0.03

Q2.24

arrow
arrow

N/A

-0.05
vs -0.04

Q3.24

arrow
arrow

N/A

-0.05
vs -0.03

Q4.24

arrow
arrow

N/A

-0.04
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+10%

227.6M  vs 206.8M

Q4.22

arrow
arrow

+7%

225.9M  vs 211.4M

Q1.23

arrow
arrow

+12%

227.1M  vs 202.2M

Q2.23

arrow
arrow

+5%

234.1M  vs 223.7M

Q3.23

arrow
arrow

+5%

240.1M  vs 227.6M

Q4.23

arrow
arrow

+8%

243.7M  vs 225.9M

Q1.24

arrow
arrow

-3%

220.3M  vs 227.1M

Q2.24

arrow
arrow

-5%

222.3M  vs 234.1M

Q3.24

arrow
arrow

-5%

227.8M  vs 240.1M

Q4.24

arrow
arrow

-2%

239.6M  vs 243.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.01

Q4.22

arrow
arrow

-16%

-0.16
vs -0.03

Q1.23

arrow
arrow

-1%

-0.01
vs -0.16

Q2.23

arrow
arrow

-1%

-0.01
vs -0.01

Q3.23

arrow
arrow

-1%

-0.01
vs -0.01

Q4.23

arrow
arrow

-6%

-0.06
vs -0.01

Q1.24

arrow
arrow

0%

-0.00
vs -0.06

Q2.24

arrow
arrow

-2%

-0.02
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

7

7
vs 9

-22%

Q4.22

arrow
arrow

6

6
vs 7

-14%

Q1.23

arrow
arrow

5

5
vs 6

-17%

Q2.23

arrow
arrow

4

4
vs 5

-20%

Q3.23

arrow
arrow

4

4
vs 4

NA

Q4.23

arrow
arrow

6

6
vs 4

50%

Q1.24

arrow
arrow

4

4
vs 6

-33%

Q2.24

arrow
arrow

4

4
vs 4

NA

Earnings Growth

Latest News